UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 205

Sortiert nach

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Leukemia, 2017-10, Vol.31 (10), p.2161-2171

2017

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Leukemia, 2016-10, Vol.30 (10), p.2047-2054

2016

Volltextzugriff (PDF)

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

Bone marrow transplantation (Basingstoke), 2016-03, Vol.51 (3), p.351-357

2016

Volltextzugriff (PDF)

IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)

Leukemia, 2017-06, Vol.31 (6), p.1363-1367

2017

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1057-1062

2015

Volltextzugriff (PDF)

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

Leukemia, 2011-05, Vol.25 (5), p.808-813

2011

Volltextzugriff (PDF)

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

Bone marrow transplantation (Basingstoke), 2019-09, Vol.54 (9), p.1391-1398

2019

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.628-633

2014

Volltextzugriff (PDF)

Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.238-244

2017

Volltextzugriff (PDF)

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients

Journal of internal medicine, 2012-11, Vol.272 (5), p.472-483

2012

Volltextzugriff (PDF)

Transplantation of Peripheral Blood Stem Cells as Compared With Bone Marrow From HLA-Identical Siblings in Adult Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2002-12, Vol.20 (24), p.4655-4664

2002

Volltextzugriff (PDF)

Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial

Leukemia, 2008-07, Vol.22 (7), p.1377-1386

2008

Volltextzugriff (PDF)

Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome

Bone marrow transplantation (Basingstoke), 2018-01, Vol.53 (1), p.94-96

2018

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.654-662

2016

Volltextzugriff (PDF)

Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.994-996

2016

Volltextzugriff (PDF)

Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma

Bone marrow transplantation (Basingstoke), 2012-11, Vol.47 (11), p.1397-1402

2012

Volltextzugriff (PDF)

Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling

Journal of cellular and molecular medicine, 2008-10, Vol.12 (5b), p.2107-2118

2008

Volltextzugriff (PDF)

Radioimmunoconjugates in acute leukemia treatment: the future is radiant

Bone marrow transplantation (Basingstoke), 2005-12, Vol.36 (12), p.1021-1026

2005

Volltextzugriff (PDF)

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1567-1574

1997

Volltextzugriff (PDF)

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.837-842

2013

Volltextzugriff (PDF)

Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2009-09, Vol.27 (27), p.4570-4577

2009

Volltextzugriff (PDF)

HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia

Leukemia, 2007, Vol.21 (1), p.129-135

2007

Volltextzugriff (PDF)

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Bone marrow transplantation (Basingstoke), 2019-01, Vol.54 (1), p.44-52

2019

Volltextzugriff (PDF)

Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.423-430

2022

Volltextzugriff (PDF)

The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML

Cytotherapy (Oxford, England), 2001-05, Vol.3 (3), p.175-188

Bunjes, D.

2001

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(12)
Spanisch
(8)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(137)
Life Sciences & Biomedicine
(123)
Science & Technology
(123)
Adult
(97)
Female
(95)
Male
(92)
Biological And Medical Sciences
(89)
Medical Sciences
(88)
Middle Aged
(83)
Hematology
(82)
Transplantation
(59)
Oncology
(56)
Immunology
(46)
Adolescent
(45)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(43)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(43)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(41)
Stem Cell Transplantation
(41)
Transplantation, Homologous
(38)
Aged
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients

Transplantation of Peripheral Blood Stem Cells as Compared With Bone Marrow From HLA-Identical Siblings in Adult Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial

Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT

Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma

Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling

Radioimmunoconjugates in acute leukemia treatment: the future is radiant

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients

The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML

Suchergebnisse filtern